One-Liner
Holistal empowers corporate employees and patients with holistic, science-backed tools for a balanced life, pioneering the future of corporate wellness.
Traction
With €46k MRR by December 2023 (+40% MoM) and 7 signed corporations such as Boliden AB and Origo Group AB in Sweden, Holistal is now seeking €150k Bridge funding to reach the Seed funding stage with the intention of raising €800k at €6M valuation. The Seed funding will start at the beginning of March 2024 when the company will have two to three months profitability. The Bridge investment will be used for:
- Invest in technical development to reach full order potential with existing and new customers i.e. reach profitability much faster.
- Reach 9 more customers in Sweden by the end of February 2024 and €65k MRR by the end of March 2024.
- Strengthen the team with 1 new hire in customer success and after sales support.
Market, Business Model, Financials and Team
Founded in 2018 in Stockholm, Holistal has a clear strategy on how to penetrate three markets over time:
- Primary – Corporate Wellness: Low entry barrier, short time to revenue, high competition (present market).
- Secondary – Healthcare: Medium entry barrier, long time to revenue, medium competition.
- Tertiary – Pharma: High entry barrier, long time to revenue, low competition.
Holistal is monetizing mainly through subscriptions and digital coaching sessions charged to B2B customers. Current customers vary in industries such as mining, IoT and tech and also in size with the largest being Boliden. Revenue growth is projected at 240% YoY, hitting breakeven in Q4 2023, reaching €900k MRR by end of Q4 2024.
Holistal’s team of 6 (1 full-time & 1 part-time co-founders and 4 part-time employees) with €40M previous exits, has a combined 60+ years of commercial track record in sectors such as healthcare, insurance, private equity and technology.
Competitive Advantage
Holistal is the only company that offers a fully incorporated suite that enables customers to activate, motivate and reward their employees and patients with its unique mix of tech and personalized support systems. Our business model is unique as it enables us to both generate revenue from engaged users (subscription fees) and users whose engagement reduces over time (subscription + digital coaching sessions).
With this complete suite, Holistal truly differentiates itself on the market compared with other corporate wellness tools that only rely on their apps with limited participation and engagement.
Round Details
At a €2M pre-money valuation, Holistal aims to close this bridge round by November 10, 2023. Some private investors have already committed to join with €75k. The minimum investment ticket size is €25k. We reserve the right to close the round earlier as interest in our bridge funding is high.
Holistal has previously raised €1,5M in private capital from external investors (€1M) and founders (€500k) to develop its MVP and validate the product market fit, which means that, after this investment round is secured, Holistal is fully ready for commercial uptake. Holistal is seeking to exit in 3 years at a target valuation of €150-200M (75x return of investment).
Get in Touch
Daniel Zand, co-founder and CEO, and the other founders are speaking with potential investors over the next two weeks and are keen to pitch, demo and open up their KPIs and financial plans in detail.